Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study

Autor: Qin, Shukui, Chan, Stephen L, Cheng, Ann-Lii, Kaseb, Ahmed, Vogel, Arndt, Gu, Shanzhi, Bai, Yuxian, Ren, Zhenggang, Lin, Xiaoyan, Chen, Zhendong, Jia, Weidong, Jin, Yongdong, Guo, Yabing, Hu, Xiaohua, Meng, Zhiqiang, Liang, Jun, Cheng, Ying, Xiong, Jianping, Ren, Hong, Yang, Fang, Li, Wei, Chen, Yajin, Zeng, Yong, Sultanbaev, Alexander, Pazgan-Simon, Monika, Pisetska, Margaryta, Melisi, Davide, Ponomarenko, Dmitriy, Osypchuk, Yurii, Sinielnikov, Ivan, Yang, Tsai-Sheng, Liang, Xiao, Chen, Chunxia, Wang, Linna, Zhang, Mingxiang, Xu, Li, Yuan, Xianglin, Li, Da, Ying, Jierer, Zhang, Jingdong, Zhang, Tao, Gu, Kangsheng, He, Yifu, Hao, Ping, Jiang, Da, Zhang, Shu, Xing, Baocai, Zhang, Baihong, Wang, Dong, Zhai, Xiaofeng, Liang, Houjie, Cybulska-Stopa, Bozena, Dvorkin, Mikhail, Stroyakovskiy, Daniil, Nechaeva, Marina, Yen, Chia-Jui, Su, Wei-Wen, Chen, Yen-Hao, Bondarenko, Igor, Yang, Lin, Fang, Weijia, Gomez-Martin, Carlos, Ryu, Min-Hee, Kim, Han-Sang, Kim, Jee-Hyun, Zarubenkov, Oleg, Orlova, Rashida, Poddubskaya, Elena, Fadeeva, Natalia, Makarova, Yulia, Chao, Yee, Hung, Chao-Hung, Neffa, Maryna, Vynnychenko, Oleksandr, Burgoyne, Adam, Hao, Chunyi, Mohr, Raphael U, Diaz-Beveridge, Roberto, Feliu-Batlle, Jaime, Cubillo-Gracian, Antonio, Lee, Ann-Shing, Daniele, Bruno, Antonuzzo, Lorenzo, Sangiovanni, Angelo, Gasbarrini, Antonio, Scartozzi, Mario, Ahn, Mi Sun, Oh, Sung-Yong, Orlov, Sergey, Harputluoglu, Hakan, Oksuzoglu, Berna, Hsu, Chiun, Rau, Kun-Ming, Krechkovskyi, Oleksandr, Yareshko, Vladimir, Xiong, Henry, Lee, Fa-Chyi, Jiang, Yixing, Gabayan, Afshin, Crow, Mary, Van Steenkiste, Christophe, Verset, Gontran

Publikováno v: In The Lancet 30 September-6 October 2023 402(10408):1133-1146

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Simple demographic characteristics and laboratory findings on admission may predict in-hospital mortality in patients with SARS-CoV-2 infection: development and validation of the covid-19 score.

Autor: Obremska, Marta¹ (AUTHOR), Pazgan-Simon, Monika² (AUTHOR), Budrewicz, Katarzyna³ (AUTHOR) katarzyna.budrewicz@umed.wroc.pl, Bilaszewski, Lukasz³ (AUTHOR), Wizowska, Joanna³ (AUTHOR), Jagielski, Dariusz⁴ (AUTHOR), Jankowska-Polanska, Beata⁵ (AUTHOR), Nadolny, Klaudiusz^6,7 (AUTHOR), Madowicz, Jarosław^8,9 (AUTHOR), Zuwala-Jagiello, Jolanta¹⁰ (AUTHOR), Zysko, Dorota³ (AUTHOR), Banasiak, Waldemar⁴ (AUTHOR), Simon, Krzysztof^2,11 (AUTHOR)

Publikováno v: BMC Infectious Diseases. 9/14/2021, Vol. 21 Issue 1, p1-10. 10p.

Serum concentrations of selected adipokines in virusrelated liver cirrhosis and hepatocellular carcinoma.

Autor: Pazgan-Simon, Monika¹ monikapazgansimon@gmail.com, Zuwała-Jagiełło, Jolanta², Kukla, Michał³, Grzebyk, Ewa², Simon, Krzysztof¹

Publikováno v: Clinical & Experimental Hepatology. 2020, Vol. 6 Issue 3, p235-242. 8p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.